ReviewReproductive sciences (Thousand Oaks, Calif.)2026
A Comprehensive Review on Recent Advancements in Navigating the Complexities of Polycystic Ovarian Syndrome (PCOS).
Review in Reproductive sciences (Thousand Oaks, Calif.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Polycystic Ovarian Syndrome (PCOS) is a complex endocrine disorder whose pathophysiology extends beyond classical mechanisms of insulin resistance and hyperandrogenism. This review critically synthesizes recent advances from the past seven years that challenge conventional views and highlight emerging concepts. Key controversies such as the differing metabolic and reproductive phenotypes of lean versus obese PCOS, the causal versus associative role of gut microbiota dysbiosis, and the bidirectional link between psychological disorders and endocrine imbalance are examined in light of current evidence. We integrate insights from molecular, metabolic, and neuroendocrine research to illustrate how these interrelated mechanisms influence ovulatory function, oocyte competence, and fertility outcomes. Emerging therapeutic directions, including GLP-1 receptor agonists, insulin sensitizers, and neurobehavioral interventions, are discussed with attention to safety, reproductive implications, and long-term efficacy. Overall, this review advances a framework that connects metabolic, reproductive, and psychological dimensions of PCOS, emphasizing the need for individualized, mechanism-based management strategies.
Indexed as
Identifiers
41917318What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.